Literature DB >> 12883554

A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter.

Vanessa Brès1, Rosemary E Kiernan, Laetitia K Linares, Christine Chable-Bessia, Olga Plechakova, Céline Tréand, Stephane Emiliani, Jean-Marie Peloponese, Kuan-Teh Jeang, Olivier Coux, Martin Scheffner, Monsef Benkirane.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) encodes a potent transactivator, Tat, which functions through binding to a short leader RNA, called transactivation responsive element (TAR). Recent studies suggest that Tat activates the HIV-1 long terminal repeat (LTR), mainly by adapting co-activator complexes, such as p300, PCAF and the positive transcription elongation factor P-TEFb, to the promoter. Here, we show that the proto-oncoprotein Hdm2 interacts with Tat and mediates its ubiquitination in vitro and in vivo. In addition, Hdm2 is a positive regulator of Tat-mediated transactivation, indicating that the transcriptional properties of Tat are stimulated by ubiquitination. Fusion of ubiquitin to Tat bypasses the requirement of Hdm2 for efficient transactivation, supporting the notion that ubiquitin has a non-proteolytic function in Tat-mediated transactivation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12883554     DOI: 10.1038/ncb1023

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  85 in total

1.  Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication.

Authors:  Tsai-Ling Liao; Chung-Yi Wu; Wen-Chi Su; King-Song Jeng; Michael M C Lai
Journal:  EMBO J       Date:  2010-10-05       Impact factor: 11.598

Review 2.  Ubiquitin and proteasomes in transcription.

Authors:  Fuqiang Geng; Sabine Wenzel; William P Tansey
Journal:  Annu Rev Biochem       Date:  2012-03-08       Impact factor: 23.643

3.  Identification of cellular proteins required for replication of human immunodeficiency virus type 1.

Authors:  Natallia Dziuba; Monique R Ferguson; William A O'Brien; Anthony Sanchez; Andrew J Prussia; Natalie J McDonald; Brian M Friedrich; Guangyu Li; Michael W Shaw; Jinsong Sheng; Thomas W Hodge; Donald H Rubin; James L Murray
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-20       Impact factor: 2.205

4.  HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses.

Authors:  Edwige Col; Cécile Caron; Christine Chable-Bessia; Gaelle Legube; Sylvie Gazzeri; Yasuhiko Komatsu; Minoru Yoshida; Monsef Benkirane; Didier Trouche; Saadi Khochbin
Journal:  EMBO J       Date:  2005-07-07       Impact factor: 11.598

5.  Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter.

Authors:  Céline Tréand; Isaure du Chéné; Vanessa Brès; Rosemary Kiernan; Richard Benarous; Monsef Benkirane; Stéphane Emiliani
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

6.  The role of the proteasomal ATPases and activator monoubiquitylation in regulating Gal4 binding to promoters.

Authors:  Anwarul Ferdous; Devanjan Sikder; Thomas Gillette; Kip Nalley; Thomas Kodadek; Stephen Albert Johnston
Journal:  Genes Dev       Date:  2006-12-13       Impact factor: 11.361

Review 7.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

8.  Non-proteolytic regulation of p53-mediated transcription through destabilization of the activator.promoter complex by the proteasomal ATPases.

Authors:  Young-Chan Kim; Shwu-Yuan Wu; Hyun-Suk Lim; Cheng-Ming Chiang; Thomas Kodadek
Journal:  J Biol Chem       Date:  2009-10-21       Impact factor: 5.157

9.  p53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation.

Authors:  Cheol-Hee Yoon; Sang-Yoon Kim; Se Eun Byeon; Yideul Jeong; Jinjoo Lee; Kwang Pyo Kim; Jinseu Park; Yong-Soo Bae
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

10.  Ubiquitylation of Cdk9 by Skp2 facilitates optimal Tat transactivation.

Authors:  Matjaz Barboric; Fan Zhang; Mojca Besenicar; Ana Plemenitas; B Matija Peterlin
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.